Trials / Conditions / Carcinoma, Ductal, Breast

Carcinoma, Ductal, Breast

11 registered clinical trials studyying Carcinoma, Ductal, Breast — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer NCT07214532	Natera, Inc.	N/A
Completed	Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous C NCT04498611	Seoul National University Hospital	N/A
Completed	G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast C NCT03455270	G1 Therapeutics, Inc.	Phase 1
Completed	Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery NCT03113825	Avelas Biosciences, Inc.	Phase 2
Unknown	G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locall NCT02983071	G1 Therapeutics, Inc.	Phase 1 / Phase 2
Completed	Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women NCT02576106	Centre Leon Berard	N/A
Withdrawn	Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injecti NCT02610920	Columbia University	EARLY_Phase 1
Terminated	Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Brea NCT01891357	West German Study Group	Phase 2
Completed	Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lu NCT00616135	Cytori Therapeutics	Phase 4
Unknown	Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast NCT00470236	Trans Tasman Radiation Oncology Group	N/A
Completed	Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer NCT01508546	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	Phase 3